These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 2580934)
21. Inhibitory effect of adult bovine serum on release of infectious Epstein-Barr virus from a virus-carrier cell line. Sairenji T; Hinuma Y J Natl Cancer Inst; 1975 Aug; 55(2):339-43. PubMed ID: 169373 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of the major histocompatibility antigen complex (MHC) on a series of Burkitt's lymphoma lines. Yokochi T; Inoue Y; Iwata H; Miyadai T; Kimura Y Microbiol Immunol; 1987; 31(12):1209-15. PubMed ID: 2836712 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Qualtiere LF; Pearson GR Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099 [TBL] [Abstract][Full Text] [Related]
24. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line, Dalianis T; Klein G; Andersson B Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413 [TBL] [Abstract][Full Text] [Related]
25. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies. Tsai CH; Glaser R Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827 [TBL] [Abstract][Full Text] [Related]
26. Differential expression of Epstein-Barr virus membrane antigens defined with monoclonal antibodies. Yokochi T; Clark EA; Kimura Y Virology; 1986 Jan; 148(1):114-20. PubMed ID: 3002025 [TBL] [Abstract][Full Text] [Related]
27. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus. Lidin BI; Lamon EW Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma. Pearson GR; Qualtiere LF; Klein G; Norin T; Bal IS Int J Cancer; 1979 Oct; 24(4):402-6. PubMed ID: 93578 [TBL] [Abstract][Full Text] [Related]
29. A novel early antigen associated with Epstein-Barr virus productive cycle. Freemer CS; Bertoni G; Takagi S; Sairenji T Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883 [TBL] [Abstract][Full Text] [Related]
30. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. Yokochi T; Holly RD; Clark EA J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961 [TBL] [Abstract][Full Text] [Related]
31. Intracellular synthesis of Epstein-Barr virus membrane antigen gp350/220. Inhibitory effect of monensin on its expression. Bertoni G; Nguyen QV; Humphreys RE; Sairenji T Intervirology; 1989; 30(2):61-73. PubMed ID: 2542183 [TBL] [Abstract][Full Text] [Related]
32. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity. Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967 [TBL] [Abstract][Full Text] [Related]
33. Effect of activation of the Epstein-Barr virus genome on expression of B cell differentiation antigens of Burkitt's lymphoma lines. Yokochi T; Inoue Y; Iwata H; Miyadai T; Kimura Y Microbiol Immunol; 1988; 32(9):957-64. PubMed ID: 2850450 [TBL] [Abstract][Full Text] [Related]
34. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines. Boguszaková L; Hirsch I; Brichácek B; Vonka V J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308 [TBL] [Abstract][Full Text] [Related]
35. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate. Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996 [TBL] [Abstract][Full Text] [Related]
36. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development. Jondal M; Gunven P Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292 [TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies. Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392 [TBL] [Abstract][Full Text] [Related]
38. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G; Dewey F; Klein G; Henle G; Henle W J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425 [TBL] [Abstract][Full Text] [Related]
39. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
40. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]